ClinVAP: A reporting strategy from variants to therapeutic options.
Next-generation sequencing (NGS) has become routine in oncology and opens up new avenues of therapies, particularly in personalized oncology setting. An increasing number of cases also implies a need for a more robust, automated, and reproducible processing of long lists of variants for cancer diagnosis and therapy. While solutions for the large-scale analysis of somatic variants have been implemented, existing solutions often have issues with reproducibility, scalability, and interoperability. ClinVAP is an automated pipeline which annotates, filters, and prioritizes somatic single nucleotide variants (SNVs) provided in variant call format. It augments the variant information with documented or predicted clinical effect. These annotated variants are prioritized based on driver gene status and druggability. ClinVAP is available as a fully containerized, self-contained pipeline maximizing reproducibility and scalability allowing the analysis of larger scale data. The resulting JSON-based report is suited for automated downstream processing, but ClinVAP can also automatically render the information into a user-defined template to yield a human-readable report. ClinVAP is available at https://github.com/PersonalizedOncology/ClinVAP. Supplementary data are available at Bioinformatics online.